{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:51:56Z","timestamp":1792144316626,"version":"4.4.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["P50 AG016574"],"award-info":[{"award-number":["P50 AG016574"]}]},{"name":"National Institute of Health","award":["P30 AG62677"],"award-info":[{"award-number":["P30 AG62677"]}]},{"name":"National Institute of Health","award":["U01 AG06786"],"award-info":[{"award-number":["U01 AG06786"]}]},{"name":"National Institute of Health","award":["U01 NS100620"],"award-info":[{"award-number":["U01 NS100620"]}]},{"name":"National Institute of Health","award":["R34 AG56639"],"award-info":[{"award-number":["R34 AG56639"]}]},{"DOI":"10.13039\/100007048","name":"Mayo Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Harry T. Mangurian, Jr. Foundation"},{"name":"the Little Family Foundation"},{"name":"the Mayo Clinic Ted Turner and Family Foundation LBD Functional Genomics Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,29]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alterations of cerebral glucose metabolism can be detected in patients with isolated rapid eye movement sleep behaviour disorder, a prodromal feature of neurodegenerative diseases with \u03b1-synuclein pathology. However, metabolic characteristics that determine clinical progression in isolated rapid eye movement sleep behaviour disorder and their association with other biomarkers need to be elucidated. We investigated the pattern of cerebral glucose metabolism on 18F-fluorodeoxyglucose PET in patients with isolated rapid eye movement sleep behaviour disorder, differentiating between those who clinically progressed and those who remained stable over time. Second, we studied the association between 18F-fluorodeoxyglucose PET and lower dopamine transporter availability in the putamen, another hallmark of synucleinopathies. Patients with isolated rapid eye movement sleep behaviour disorder from the Mayo Clinic Alzheimer\u2019s Disease Research Center and Center for Sleep Medicine (n = 22) and age-and sex-matched clinically unimpaired controls (clinically unimpaired; n = 44) from the Mayo Clinic Study of Aging were included. All participants underwent 18F-fluorodeoxyglucose PET and dopamine transporter imaging with iodine 123-radiolabeled 2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)-N-(3-fluoropropyl) nortropane on single-photon emission computerized tomography. A subset of patients with isolated rapid eye movement sleep behaviour disorder with follow-up evaluations (n = 17) was classified as isolated rapid eye movement sleep behaviour disorder progressors (n = 7) if they developed mild cognitive impairment or Parkinson\u2019s disease; or isolated rapid eye movement sleep behaviour disorder stables (n = 10) if they remained with a diagnosis of isolated rapid eye movement sleep behaviour disorder with no cognitive impairment. Glucose metabolic abnormalities in isolated rapid eye movement sleep behaviour disorder were determined by comparing atlas-based regional 18F-fluorodeoxyglucose PET uptake between isolated rapid eye movement sleep behaviour disorder and clinically unimpaired. Associations between 18F-fluorodeoxyglucose PET and dopamine transporter availability in the putamen were analyzed with Pearson\u2019s correlation within the nigrostriatal pathway structures and with voxel-based analysis in the cortex. Patients with isolated rapid eye movement sleep behaviour disorder had lower glucose metabolism in the substantia nigra, retrosplenial cortex, angular cortex, and thalamus, and higher metabolism in the amygdala and entorhinal cortex compared with clinically unimpaired. Patients with isolated rapid eye movement sleep behaviour disorder who clinically progressed over time were characterized by higher glucose metabolism in the amygdala and entorhinal cortex, and lower glucose metabolism in the cerebellum compared with clinically unimpaired. Lower dopamine transporter availability in the putamen was associated with higher glucose metabolism in the pallidum within the nigrostriatal pathway; and with higher 18F-fluorodeoxyglucose uptake in the amygdala, insula, and temporal pole on a voxel-based analysis, although these associations did not survive after correcting for multiple comparisons. Our findings suggest that cerebral glucose metabolism in isolated rapid eye movement sleep behaviour disorder is characterized by hypometabolism in regions frequently affected during the prodromal stage of synucleinopathies, potentially reflecting synaptic dysfunction. Hypermetabolism is also seen in isolated rapid eye movement sleep behaviour disorder, suggesting that synaptic metabolic disruptions may be leading to a lack of inhibition, compensatory mechanisms, or microglial activation, especially in regions associated with nigrostriatal degeneration.<\/jats:p>","DOI":"10.1093\/braincomms\/fcad021","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T23:27:55Z","timestamp":1675294075000},"source":"Crossref","is-referenced-by-count":21,"title":["Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder"],"prefix":"10.1093","volume":"5","author":[{"given":"Patricia","family":"Diaz-Galvan","sequence":"first","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toji","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Przybelski","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Science, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G","family":"Lesnick","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Science, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L","family":"Senjem","sequence":"additional","affiliation":[{"name":"Department of Information Technology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr","given":"Clifford R","family":"Jack","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah K","family":"Forsberg","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon-Ki","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-8826","authenticated-orcid":false,"given":"Erik K","family":"St. Louis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Fields","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo E","family":"Benarroch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-8187","authenticated-orcid":false,"given":"Bradley F","family":"Boeve","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-2081","authenticated-orcid":false,"given":"Kejal","family":"Kantarci","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"issue":"2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","article-title":"Chronic behavioral disorders of human REM sleep: A new category of parasomnia","volume":"25","author":"Schenck","year":"2002","journal-title":"Sleep"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.05115.x","article-title":"REM Sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions","volume":"1184","author":"Boeve","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/brain\/123.2.331","article-title":"Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases","volume":"123","author":"Olson","year":"2000","journal-title":"Brain"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk\/\/predictors of dementia\/\/parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder\/\/neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord."},{"issue":"8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.sleep.2012.10.015","article-title":"Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder","volume":"14","author":"Boeve","year":"2013","journal-title":"Sleep Med."},{"issue":"Pt 11","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","article-title":"Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease","volume":"130","author":"Boeve","year":"2007","journal-title":"Brain"},{"issue":"8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: Devising controlled active treatment studies for symptomatic and neuroprotective therapy\u2014A consensus statement from the international rapid eye movement sleep behavior disorder study group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"issue":"8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1474-4422(21)00176-9","article-title":"Biomarkers of conversion to \u03b1-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder","volume":"20","author":"Miglis","year":"2021","journal-title":"Lancet Neurol"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1148\/rg.343135065","article-title":"Brain PET in suspected dementia: Patterns of altered FDG metabolism","volume":"34","author":"Brown","year":"2014","journal-title":"Radiographics"},{"issue":"5","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.23631","article-title":"Metabolic brain networks in translational neurology: Concepts and applications","volume":"72","author":"Niethammer","year":"2012","journal-title":"Ann Neurol"},{"issue":"10","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","article-title":"The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies","volume":"50","author":"Lim","year":"2009","journal-title":"J Nucl Med"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nicl.2014.06.007","article-title":"Parkinson\u2019s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging","volume":"5","author":"Teune","year":"2014","journal-title":"Neuroimage Clin"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/mds.25361","article-title":"Validation of parkinsonian disease-related metabolic brain patterns","volume":"28","author":"Teune","year":"2013","journal-title":"Mov Disord"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102754","article-title":"FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD","volume":"31","author":"Kantarci","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"17","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnagi.2019.00303","article-title":"Parkinson\u2019s disease-mild cognitive impairment (PD-MCI): A useful summary of update knowledge","volume":"11","author":"Cammisuli","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"9","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2967\/jnumed.117.202242","article-title":"The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson disease","volume":"59","author":"Meles","year":"2018","journal-title":"J Nucl Med."},{"issue":"Pt 12","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1093\/brain\/awu290","article-title":"Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder","volume":"137","author":"Wu","year":"2014","journal-title":"Brain"},{"issue":"6","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","article-title":"Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies","volume":"82","author":"Kaasinen","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/brain\/awaa365","article-title":"Dopaminergic imaging\/\/clinical predictors for phenoconversion of REM sleep behaviour disorder","volume":"144","author":"Arnaldi","year":"2021","journal-title":"Brain"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.25026","article-title":"Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder","volume":"82","author":"Iranzo","year":"2017","journal-title":"Ann Neurol."},{"key":"2023022215175294100_","first-page":"51","volume-title":"International classification of sleep disorders","author":"Medicine AAoS","year":"2005","edition":"2nd edn"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The mayo clinic study of aging: Design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"issue":"16","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson\u2019s disease dementia: Recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov Disord"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"591\u2013","DOI":"10.1002\/alz.12411","article-title":"The temporal onset of the core features in dementia with Lewy bodies","volume":"18","author":"Choudhury","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"Suppl 2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"S671","DOI":"10.1002\/mds.22600","article-title":"Clinical measures of progression in Parkinson\u2019s disease","volume":"24","author":"Poewe","year":"2009","journal-title":"Mov Disord"},{"issue":"2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1212\/WNL.62.2.181","article-title":"DLB Fluctuations: Specific features that reliably differentiate DLB from AD and normal aging","volume":"62","author":"Ferman","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2967\/jnumed.119.239418","article-title":"Confirmation of 123I-FP-CIT SPECT quantification methods in dementia with Lewy bodies and other neurodegenerative disorders","volume":"61","author":"Maltais","year":"2020","journal-title":"J Nucl Med"},{"issue":"7S_Part_16","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"P792","DOI":"10.1016\/j.jalz.2017.06.1071","article-title":"[P2\u2013415]: THE MAYO CLINIC ADULT LIFESPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFESPAN","volume":"13","author":"Schwarz","year":"2017","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neuroimage.2017.05.015","article-title":"Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity","volume":"170","author":"Ewert","year":"2018","journal-title":"Neuroimage"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/sim.7986","article-title":"Estimating the receiver operating characteristic curve in matched case control studies","volume":"38","author":"Xu","year":"2019","journal-title":"Stat Med"},{"issue":"12","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/jcbfm.2015.173","article-title":"Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder","volume":"35","author":"Ge","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.parkreldis.2019.03.017","article-title":"Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and \u03b1-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study","volume":"64","author":"Liguori","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"issue":"6","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.smrv.2008.11.003","article-title":"The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases","volume":"13","author":"Iranzo","year":"2009","journal-title":"Sleep Med Rev"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fneur.2015.00123","article-title":"REM Sleep at its core - circuits, neurotransmitters, and pathophysiology","volume":"6","author":"Fraigne","year":"2015","journal-title":"Front Neurol"},{"issue":"23","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1523\/JNEUROSCI.5632-12.2013","article-title":"Amygdala lesions reduce cataplexy in orexin knock-out mice","volume":"33","author":"Burgess","year":"2013","journal-title":"J Neurosci"},{"issue":"2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2012.07.059","article-title":"Projections from the central nucleus of the amygdala to the nucleus pontis oralis in the rat: An anterograde labeling study","volume":"525","author":"Zhang","year":"2012","journal-title":"Neurosci Lett"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.physbeh.2005.06.033","article-title":"Sleep-related neurons in the central nucleus of the amygdala of rats and their modulation by the dorsal raphe nucleus","volume":"86","author":"Jha","year":"2005","journal-title":"Physiol Behav"},{"issue":"2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.13050","article-title":"Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer\u2019s disease?","volume":"25","author":"Merlo","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2017.06.016","article-title":"Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: Neuroimaging evidence for protection and compensation","volume":"59","author":"Arenaza-Urquijo","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"13","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","article-title":"Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment","volume":"79","author":"Scheef","year":"2012","journal-title":"Neurology"},{"issue":"47","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of abeta in mild cognitive impairment: An example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J Neurosci"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","article-title":"Cortical hypermetabolism in MCI subjects: A compensatory mechanism?","volume":"42","author":"Ashraf","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13195-020-00702-6","article-title":"FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels","volume":"12","author":"Rubinski","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","article-title":"Physiological release of endogenous tau is stimulated by neuronal activity","volume":"14","author":"Pooler","year":"2013","journal-title":"EMBO Rep"},{"issue":"8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat Neurosci"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2018.01.002","article-title":"Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation","volume":"65","author":"Apostolova","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/ijms18040785","article-title":"Translocator protein-18\u2005kDa (TSPO) positron emission tomography (PET) imaging and its clinical impact in neurodegenerative diseases","volume":"18","author":"Dupont","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","DOI":"10.1042\/AN20130045","article-title":"Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a\/B polarized cells","volume":"6","author":"Lisi","year":"2014","journal-title":"ASN Neuro"},{"issue":"8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00005-012-0181-2","article-title":"The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer\u2019s disease brain","volume":"60","author":"Varnum","year":"2012","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/627325","article-title":"Microglia: An active player in the regulation of synaptic activity","volume":"2013","author":"Ji","year":"2013","journal-title":"Neural Plast"},{"issue":"13","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/npp.2014.164","article-title":"Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease","volume":"39","author":"Jiang","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12035-016-9704-x","article-title":"TREM2 Overexpression has No improvement on neuropathology and cognitive impairment in aging APPswe\/PS1dE9 mice","volume":"54","author":"Jiang","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"615","key":"2023022215175294100_","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5640","article-title":"Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases","volume":"13","author":"Xiang","year":"2021","journal-title":"Sci Transl Med"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.conb.2014.07.008","article-title":"Dopaminergic modulation of striatal networks in health and Parkinson\u2019s disease","volume":"29","author":"Surmeier","year":"2014","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/brain\/awaa019","article-title":"Network degeneration in Parkinson\u2019s disease: Multimodal imaging of nigro-striato-cortical dysfunction","volume":"143","author":"Ruppert","year":"2020","journal-title":"Brain"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","article-title":"REM Sleep behaviour disorder","volume":"4","author":"Dauvilliers","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2017.03.002","article-title":"Selective activation of a few limbic structures during paradoxical (REM) sleep by the claustrum and the supramammillary nucleus: Evidence and function","volume":"44","author":"Luppi","year":"2017","journal-title":"Curr Opin Neurobiol"},{"issue":"9","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","article-title":"Dementia with Lewy bodies: Basis of cingulate island sign","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","article-title":"Multimodality imaging characteristics of dementia with Lewy bodies","volume":"33","author":"Kantarci","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/mds.28592","article-title":"Longitudinal changes in isolated rapid eye movement sleep behavior disorder-related metabolic pattern expression","volume":"36","author":"Kim","year":"2021","journal-title":"Mov Disord"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0271678X19828916","article-title":"Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder","volume":"40","author":"Huang","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/mds.27094","article-title":"FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder","volume":"32","author":"Meles","year":"2017","journal-title":"Mov Disord"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fnins.2019.00617","article-title":"Brain molecular connectivity in neurodegenerative diseases: Recent advances and new perspectives using positron emission tomography","volume":"13","author":"Sala","year":"2019","journal-title":"Front Neurosci"},{"issue":"7","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ene.14215","article-title":"In-vivo signatures of neurodegeneration in isolated rapid eye movement sleep behaviour disorder","volume":"27","author":"Carli","year":"2020","journal-title":"Eur J Neurol"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.parkreldis.2018.12.020","article-title":"Gray matter substrates of depressive\/\/anxiety symptoms in idiopathic REM sleep behavior disorder","volume":"62","author":"Bourgouin","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"issue":"7","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","article-title":"In-vivo staging of pathology in REM sleep behaviour disorder: A multimodality imaging case-control study","volume":"17","author":"Knudsen","year":"2018","journal-title":"Lancet Neurol"},{"key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-neuro-070918-050258","article-title":"The theory and neuroscience of cerebellar cognition","volume":"42","author":"Schmahmann","year":"2019","journal-title":"Annu Rev Neurosci"},{"issue":"Pt 6","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","article-title":"Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson\u2019s disease and controls","volume":"123","author":"Eisensehr","year":"2000","journal-title":"Brain"},{"issue":"11","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","article-title":"Decreased striatal dopamine transporter uptake\/\/substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A prospective study [corrected]","volume":"9","author":"Iranzo","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"9","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","article-title":"Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A prospective study","volume":"10","author":"Iranzo","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1331.2009.02854.x","article-title":"The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder","volume":"17","author":"Kim","year":"2010","journal-title":"Eur J Neurol"},{"issue":"Pt 8","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/brain\/aww124","article-title":"Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson\u2019s disease","volume":"139","author":"Rolinski","year":"2016","journal-title":"Brain"},{"issue":"11","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.sleep.2013.06.008","article-title":"Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder","volume":"14","author":"Rupprecht","year":"2013","journal-title":"Sleep Med"},{"issue":"Pt 1","key":"2023022215175294100_","first-page":"126","article-title":"Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT","volume":"128","author":"Stiasny-Kolster","year":"2005","journal-title":"Brain"},{"issue":"1","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"15463","DOI":"10.1038\/s41598-019-51710-y","article-title":"Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder","volume":"9","author":"Du\u0161ek","year":"2019","journal-title":"Sci Rep"},{"issue":"16","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.0000000000003838","article-title":"Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases","volume":"88","author":"Li","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10286-020-00674-5","article-title":"Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder","volume":"30","author":"McCarter","year":"2020","journal-title":"Clin Auton Res"},{"issue":"11","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaneurol.2015.2397","article-title":"Basal ganglia circuits as targets for neuromodulation in Parkinson disease","volume":"72","author":"DeLong","year":"2015","journal-title":"JAMA Neurol"},{"issue":"6","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","article-title":"Circuit mechanisms of Parkinson\u2019s disease","volume":"101","author":"McGregor","year":"2019","journal-title":"Neuron"},{"issue":"20","key":"2023022215175294100_","doi-asserted-by":"crossref","first-page":"e1759","DOI":"10.1212\/WNL.0000000000005523","article-title":"Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder","volume":"90","author":"Rahayel","year":"2018","journal-title":"Neurology"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcad021\/49043154\/fcad021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/5\/1\/fcad021\/49295991\/fcad021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/5\/1\/fcad021\/49295991\/fcad021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T18:23:03Z","timestamp":1679595783000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcad021\/7023585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,29]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcad021","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,12,29]]},"article-number":"fcad021"}}